avrg: SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SOX3
|
ENSG00000134595.6 | SRY-box transcription factor 3 |
SOX2
|
ENSG00000181449.2 | SRY-box transcription factor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SOX2 | hg19_v2_chr3_+_181429704_181429722 | 0.36 | 1.1e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 24.6 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
4.6 | 13.9 | GO:0043315 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
2.5 | 12.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
2.5 | 9.9 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
2.1 | 10.5 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
1.9 | 7.7 | GO:0043542 | endothelial cell migration(GO:0043542) |
1.9 | 7.5 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
1.8 | 17.9 | GO:1990834 | response to odorant(GO:1990834) |
1.7 | 1.7 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.7 | 31.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.7 | 11.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.7 | 6.6 | GO:0070894 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
1.5 | 5.9 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
1.4 | 8.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.4 | 4.3 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
1.4 | 4.2 | GO:1904237 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
1.4 | 36.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.4 | 4.2 | GO:0021503 | neural fold bending(GO:0021503) |
1.4 | 13.9 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
1.4 | 4.1 | GO:0008057 | eye pigment granule organization(GO:0008057) |
1.3 | 8.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
1.3 | 1.3 | GO:0060594 | mammary gland specification(GO:0060594) |
1.3 | 3.8 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
1.3 | 6.3 | GO:0051622 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
1.2 | 3.7 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.2 | 15.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.2 | 7.2 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
1.2 | 9.6 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
1.1 | 1.1 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
1.1 | 10.8 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.1 | 2.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.1 | 3.2 | GO:0042938 | dipeptide transport(GO:0042938) |
1.0 | 3.1 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
1.0 | 35.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.0 | 4.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.0 | 2.9 | GO:0060129 | regulation of calcium-independent cell-cell adhesion(GO:0051040) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
1.0 | 2.9 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
1.0 | 5.8 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.0 | 2.9 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.9 | 8.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.9 | 4.7 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.9 | 10.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.9 | 2.7 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.9 | 4.3 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.9 | 9.5 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.9 | 4.3 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.9 | 1.7 | GO:0001300 | chronological cell aging(GO:0001300) |
0.8 | 12.3 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.8 | 3.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.8 | 2.4 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.8 | 7.0 | GO:0021564 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) vagus nerve development(GO:0021564) |
0.8 | 3.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.8 | 3.9 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.8 | 13.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.8 | 11.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.8 | 4.6 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.8 | 3.8 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.8 | 3.0 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.8 | 0.8 | GO:0035802 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
0.7 | 5.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.7 | 5.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.7 | 5.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.7 | 1.5 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.7 | 3.6 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.7 | 12.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.7 | 2.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.7 | 2.1 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.7 | 13.0 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.7 | 3.3 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
0.6 | 4.5 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.6 | 5.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.6 | 3.8 | GO:0030421 | defecation(GO:0030421) |
0.6 | 4.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.6 | 5.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.6 | 3.7 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.6 | 4.3 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.6 | 12.4 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.6 | 1.9 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
0.6 | 5.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.6 | 1.2 | GO:0070831 | basement membrane assembly(GO:0070831) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.6 | 2.4 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.6 | 19.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 1.8 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.6 | 3.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.6 | 5.9 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.6 | 2.3 | GO:0044417 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
0.5 | 3.8 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.5 | 4.3 | GO:0072553 | terminal button organization(GO:0072553) |
0.5 | 2.7 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.5 | 3.2 | GO:0018032 | protein amidation(GO:0018032) |
0.5 | 1.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.5 | 2.7 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.5 | 3.7 | GO:1903786 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.5 | 6.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 3.7 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.5 | 3.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.5 | 2.1 | GO:0044334 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.5 | 7.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 8.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.5 | 1.5 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.5 | 2.6 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.5 | 3.0 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.5 | 2.5 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.5 | 4.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 16.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.5 | 3.5 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.5 | 8.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.5 | 1.5 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
0.5 | 8.8 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.5 | 8.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.5 | 1.4 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.5 | 1.9 | GO:2001162 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
0.5 | 2.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.5 | 2.8 | GO:1901910 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.5 | 0.9 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.5 | 2.8 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.5 | 0.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 2.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.5 | 6.4 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.5 | 1.8 | GO:0006788 | heme oxidation(GO:0006788) |
0.5 | 2.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 2.3 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.4 | 1.3 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.4 | 1.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.4 | 2.2 | GO:0035936 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.4 | 3.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 1.7 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.4 | 7.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.4 | 8.5 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.4 | 4.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 2.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.4 | 1.3 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.4 | 2.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.4 | 3.7 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 2.9 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.4 | 2.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 2.5 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.4 | 4.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.4 | 1.6 | GO:0035425 | autocrine signaling(GO:0035425) |
0.4 | 5.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.4 | 3.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.4 | 2.4 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.4 | 1.2 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.4 | 2.4 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.4 | 3.6 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.4 | 6.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.4 | 19.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.4 | 2.4 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.4 | 3.9 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.4 | 1.5 | GO:0018277 | protein deamination(GO:0018277) |
0.4 | 2.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 1.1 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
0.4 | 1.9 | GO:1904448 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.4 | 3.7 | GO:0015808 | L-alanine transport(GO:0015808) |
0.4 | 1.5 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
0.4 | 2.9 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.4 | 1.1 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
0.4 | 4.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.4 | 3.2 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.4 | 1.4 | GO:0009956 | radial pattern formation(GO:0009956) |
0.3 | 1.7 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.3 | 0.3 | GO:0099545 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
0.3 | 4.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.3 | 0.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 1.7 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.3 | 1.0 | GO:0031247 | actin rod assembly(GO:0031247) |
0.3 | 2.3 | GO:0021759 | globus pallidus development(GO:0021759) |
0.3 | 1.7 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.3 | 4.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 4.0 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.3 | 1.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 3.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.3 | 2.6 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.3 | 2.9 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 18.0 | GO:1901998 | toxin transport(GO:1901998) |
0.3 | 4.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 1.0 | GO:0061145 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
0.3 | 1.6 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.3 | 2.2 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.3 | 0.6 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.3 | 0.6 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.3 | 4.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 1.5 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.3 | 0.3 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.3 | 2.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 1.5 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.3 | 2.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.3 | 3.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 0.9 | GO:1990637 | response to prolactin(GO:1990637) |
0.3 | 9.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.3 | 2.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 5.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 3.2 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
0.3 | 0.8 | GO:1902744 | negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
0.3 | 40.7 | GO:0070268 | cornification(GO:0070268) |
0.3 | 0.3 | GO:0003032 | detection of oxygen(GO:0003032) |
0.3 | 1.7 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.3 | 0.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.3 | 7.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 1.4 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.3 | 0.8 | GO:2000974 | auditory receptor cell fate determination(GO:0042668) negative regulation of pro-B cell differentiation(GO:2000974) |
0.3 | 1.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.3 | 0.8 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 5.4 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.3 | 4.1 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 3.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 3.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 1.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.3 | 2.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.3 | 0.5 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.2 | 0.7 | GO:1900737 | negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.2 | 5.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.2 | 1.0 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.2 | 1.0 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.2 | 1.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.2 | 2.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 1.4 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 4.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 3.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.7 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) positive regulation of potassium ion import(GO:1903288) |
0.2 | 3.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.7 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 1.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 2.3 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.2 | 0.9 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 1.4 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.2 | 2.0 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.2 | 1.8 | GO:1990253 | positive regulation of TORC1 signaling(GO:1904263) cellular response to leucine starvation(GO:1990253) |
0.2 | 7.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.9 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.2 | 3.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.2 | 2.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 6.5 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.2 | 10.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.7 | GO:1904247 | modification by virus of host mRNA processing(GO:0046778) regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.2 | 6.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 3.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 4.2 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 3.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 1.5 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.2 | 1.5 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.2 | 0.6 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 2.2 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.2 | 0.6 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
0.2 | 2.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.2 | 0.6 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.2 | 2.9 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.2 | 1.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 3.3 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.2 | 3.9 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.2 | 1.6 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 4.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 3.6 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 5.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 6.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 0.6 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.2 | 5.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 1.8 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.2 | 7.3 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.2 | 1.0 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.2 | 1.8 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.2 | 4.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 11.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.2 | 1.8 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 1.7 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.2 | 0.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 3.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 1.2 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.2 | 5.4 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.2 | 0.6 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.2 | 0.9 | GO:2000973 | midbrain morphogenesis(GO:1904693) regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 1.9 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 4.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 3.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 1.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 1.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 1.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 14.6 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 0.9 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.2 | 4.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 9.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 1.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 0.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 2.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 20.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 0.9 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.2 | 0.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 2.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.5 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 0.7 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) |
0.2 | 1.9 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.2 | 2.0 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.2 | 3.4 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.2 | 7.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 1.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) seminal vesicle development(GO:0061107) |
0.2 | 1.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 0.7 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.2 | 2.3 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.2 | 0.8 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.2 | 1.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 1.0 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.2 | 0.5 | GO:1903336 | intralumenal vesicle formation(GO:0070676) negative regulation of vacuolar transport(GO:1903336) |
0.2 | 1.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 1.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 2.5 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 0.3 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 6.8 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.2 | 3.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 1.1 | GO:0051918 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.6 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 3.7 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 5.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.1 | 26.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 13.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 1.3 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.3 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 1.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.6 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.1 | 0.4 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.1 | 0.3 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 1.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.3 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.1 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.4 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.1 | 2.2 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 4.0 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 4.9 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 1.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 1.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.8 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.1 | 1.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 1.3 | GO:1902218 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 4.2 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 6.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 2.1 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 2.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.5 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 3.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 4.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 5.6 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 2.7 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.1 | 1.3 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.1 | 1.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 2.8 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 1.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 1.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.6 | GO:0048864 | stem cell development(GO:0048864) |
0.1 | 0.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 13.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 6.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.5 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.1 | 0.6 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.7 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 1.0 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.1 | 0.6 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 1.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 0.7 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
0.1 | 1.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 2.3 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:1904798 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
0.1 | 0.3 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.1 | 0.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.4 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.1 | 2.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 2.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 4.6 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.6 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 3.1 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 2.1 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.1 | 1.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 1.7 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 1.2 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 2.1 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 3.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.8 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 2.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.9 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 2.7 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 2.4 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.1 | 0.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 2.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 3.9 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.1 | 5.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.7 | GO:1905216 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.1 | 0.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 3.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 1.8 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 1.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 1.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 1.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.5 | GO:0043305 | negative regulation of mast cell activation involved in immune response(GO:0033007) negative regulation of mast cell degranulation(GO:0043305) |
0.1 | 0.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.7 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 2.1 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.1 | 0.4 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 2.7 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.1 | 0.6 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.7 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.7 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 1.6 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 0.4 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.1 | 0.2 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 1.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 2.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 1.9 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 1.7 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.1 | 1.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 1.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.5 | GO:0060348 | bone development(GO:0060348) |
0.1 | 0.8 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 2.8 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 1.2 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.1 | 0.4 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 5.4 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 2.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 2.9 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 1.7 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.9 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.1 | 0.4 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.1 | 0.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 3.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.4 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.1 | 3.0 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.7 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.7 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 2.6 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.1 | 0.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 7.7 | GO:0043547 | regulation of GTPase activity(GO:0043087) positive regulation of GTPase activity(GO:0043547) |
0.1 | 1.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 1.3 | GO:0042278 | purine nucleoside metabolic process(GO:0042278) |
0.1 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.7 | GO:1903725 | regulation of phospholipid metabolic process(GO:1903725) |
0.1 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.7 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.3 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.1 | 1.6 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.3 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 2.9 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 0.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 2.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.5 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 5.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 1.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 1.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) |
0.1 | 1.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.9 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.7 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.0 | 0.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.2 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.9 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.0 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) oxygen metabolic process(GO:0072592) |
0.0 | 0.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.5 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 1.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.6 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 2.8 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.3 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.0 | 1.5 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 1.5 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.5 | GO:0051258 | protein polymerization(GO:0051258) |
0.0 | 0.3 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.0 | 1.4 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.0 | 4.9 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 1.0 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 4.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.3 | GO:0022604 | regulation of cell morphogenesis(GO:0022604) |
0.0 | 2.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.6 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 6.8 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.2 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
0.0 | 4.7 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.0 | 0.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.3 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) cell differentiation involved in salivary gland development(GO:0060689) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.0 | 0.4 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.2 | GO:0007034 | vacuolar transport(GO:0007034) |
0.0 | 0.6 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.0 | 1.8 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.7 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 1.0 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.0 | 0.3 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 0.5 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.0 | 1.0 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 2.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 6.6 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.8 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.5 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 0.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.3 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.0 | 0.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 1.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.8 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.0 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 3.7 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.6 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) negative regulation of kinase activity(GO:0033673) |
0.0 | 1.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 1.2 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.9 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.4 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.0 | 0.3 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 1.1 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.0 | 0.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.3 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) |
0.0 | 0.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.3 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.1 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.9 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.4 | GO:0042594 | response to starvation(GO:0042594) |
0.0 | 0.3 | GO:0000956 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.0 | 0.3 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.0 | 0.2 | GO:0090287 | regulation of cellular response to growth factor stimulus(GO:0090287) |
0.0 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.4 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.2 | GO:1905245 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.0 | 0.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 1.9 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.4 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.1 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.6 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.2 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 0.7 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 1.0 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 0.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.2 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.0 | 1.3 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.0 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.9 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.6 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
2.9 | 23.2 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
2.4 | 7.2 | GO:0005595 | collagen type XII trimer(GO:0005595) |
2.0 | 5.9 | GO:1990032 | parallel fiber(GO:1990032) |
1.9 | 20.7 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.7 | 5.0 | GO:0008623 | CHRAC(GO:0008623) |
1.1 | 35.4 | GO:0030056 | hemidesmosome(GO:0030056) |
1.1 | 3.3 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
1.0 | 8.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
1.0 | 15.8 | GO:0043219 | lateral loop(GO:0043219) |
1.0 | 2.9 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
1.0 | 2.9 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.8 | 0.8 | GO:0044609 | DBIRD complex(GO:0044609) |
0.8 | 6.4 | GO:0032437 | cuticular plate(GO:0032437) |
0.8 | 6.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.7 | 2.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.7 | 3.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.7 | 17.2 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.6 | 17.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 3.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.6 | 2.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.6 | 1.7 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.6 | 4.5 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
0.6 | 2.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.5 | 22.4 | GO:0030057 | desmosome(GO:0030057) |
0.5 | 16.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.5 | 1.6 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.5 | 14.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.5 | 2.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.5 | 5.9 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.5 | 6.8 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 7.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.4 | 3.6 | GO:1990357 | terminal web(GO:1990357) |
0.4 | 4.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.4 | 2.2 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.4 | 4.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.4 | 4.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 13.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.4 | 1.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.4 | 4.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 4.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 3.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.4 | 10.1 | GO:0097386 | glial cell projection(GO:0097386) |
0.4 | 2.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.4 | 1.9 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.4 | 3.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 5.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 12.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 2.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 29.8 | GO:0045095 | keratin filament(GO:0045095) |
0.4 | 7.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.4 | 1.1 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.4 | 13.8 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.4 | 3.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.3 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 14.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.3 | 5.5 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 1.0 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.3 | 2.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 3.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 0.9 | GO:0000502 | proteasome complex(GO:0000502) |
0.3 | 1.8 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 3.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 1.1 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.3 | 3.8 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 1.6 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.3 | 5.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 3.2 | GO:0032059 | bleb(GO:0032059) |
0.3 | 0.8 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.3 | 8.8 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.7 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.2 | 1.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 1.5 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.2 | 4.3 | GO:0043197 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.2 | 1.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 0.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.2 | 1.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 0.7 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
0.2 | 2.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 4.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 7.7 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 5.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 5.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 3.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.6 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.2 | 1.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 1.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 13.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 23.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 3.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 1.5 | GO:0002177 | manchette(GO:0002177) |
0.2 | 1.7 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 5.8 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 1.6 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.2 | 2.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.2 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 15.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 2.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 1.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 0.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 4.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.9 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.1 | 20.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 0.6 | GO:0060187 | cell pole(GO:0060187) |
0.1 | 13.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.5 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 1.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 1.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 3.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 2.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 2.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 7.4 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.8 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 2.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 16.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 2.0 | GO:0097433 | dense body(GO:0097433) |
0.1 | 19.9 | GO:0016605 | PML body(GO:0016605) |
0.1 | 3.5 | GO:0043034 | costamere(GO:0043034) |
0.1 | 2.0 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 1.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 1.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 3.1 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 1.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 1.6 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 3.8 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 1.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.5 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.3 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.1 | 4.9 | GO:1990752 | microtubule end(GO:1990752) |
0.1 | 4.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 14.2 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 3.8 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 81.3 | GO:0070161 | anchoring junction(GO:0070161) |
0.1 | 6.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 0.9 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 2.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 3.8 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 1.5 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.6 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.1 | 0.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.6 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 2.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.8 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 2.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 6.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.5 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 2.0 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 8.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.7 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.9 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 3.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 1.2 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 3.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 2.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 2.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 2.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.5 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.1 | 0.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 7.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 1.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 5.9 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 4.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 1.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 1.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 6.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 3.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.7 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.6 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 3.7 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 16.4 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 1.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.5 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 3.6 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 1.4 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 19.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.4 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.0 | 0.2 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.0 | 1.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.0 | 2.3 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 1.5 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 6.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 1.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 3.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 1.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 4.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.7 | GO:0044216 | host(GO:0018995) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 2.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 1.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.7 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.3 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.3 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 0.8 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.5 | GO:0030424 | axon(GO:0030424) |
0.0 | 1.0 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.7 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 0.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 1.4 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.7 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.3 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 1.3 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 1.4 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 2.2 | GO:0019867 | outer membrane(GO:0019867) |
0.0 | 1.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.0 | GO:0034706 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
0.0 | 0.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 19.7 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
3.9 | 11.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
2.2 | 6.7 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
2.0 | 30.6 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
2.0 | 13.9 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
1.9 | 11.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.7 | 6.7 | GO:0008431 | vitamin E binding(GO:0008431) |
1.6 | 25.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.4 | 4.3 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
1.3 | 6.3 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
1.3 | 3.8 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
1.2 | 3.7 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
1.2 | 3.5 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
1.0 | 9.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.0 | 12.9 | GO:0097016 | L27 domain binding(GO:0097016) |
1.0 | 3.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.0 | 2.9 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
1.0 | 3.8 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.9 | 4.7 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.9 | 3.5 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.9 | 6.0 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.9 | 7.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.8 | 5.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.8 | 3.4 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.8 | 4.0 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.8 | 9.5 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.7 | 2.2 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.7 | 2.9 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.7 | 4.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.7 | 13.9 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.7 | 21.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.7 | 16.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.7 | 12.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.7 | 6.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.7 | 2.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.7 | 2.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.7 | 19.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.6 | 9.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.6 | 6.0 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.6 | 4.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.6 | 3.0 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.6 | 4.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 3.5 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.6 | 1.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.6 | 14.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 8.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.5 | 3.2 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.5 | 3.2 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.5 | 2.6 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.5 | 4.7 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.5 | 8.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.5 | 5.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 1.5 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.5 | 2.0 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.5 | 2.4 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.5 | 3.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.5 | 0.9 | GO:0005503 | all-trans retinal binding(GO:0005503) |
0.5 | 4.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 2.8 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.5 | 1.4 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.5 | 1.8 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.5 | 4.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 1.3 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.4 | 1.3 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.4 | 3.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 1.8 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.4 | 6.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 1.7 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.4 | 3.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.4 | 5.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 2.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.4 | 3.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.4 | 2.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.4 | 6.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 3.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 7.2 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.4 | 4.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 2.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 7.5 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.4 | 1.9 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.4 | 1.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.4 | 3.7 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.4 | 1.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.4 | 2.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.4 | 2.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.4 | 1.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.4 | 1.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 6.0 | GO:0019841 | retinol binding(GO:0019841) |
0.4 | 3.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 5.1 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.3 | 26.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.3 | 1.7 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.3 | 3.0 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.3 | 7.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 16.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 14.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 3.8 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.3 | 46.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 1.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 0.9 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.3 | 2.5 | GO:0042835 | BRE binding(GO:0042835) |
0.3 | 2.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 4.9 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.3 | 1.8 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 1.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.3 | 5.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 6.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 6.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 8.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.3 | 2.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 4.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 3.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 8.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 0.8 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 3.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 2.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 5.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.3 | 3.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 3.6 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 11.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 4.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 2.1 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.2 | 6.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 3.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 1.7 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 7.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 1.2 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.2 | 0.9 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.2 | 4.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 2.1 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 1.4 | GO:0045174 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.2 | 0.7 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.9 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.2 | 1.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 5.8 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 5.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 6.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 4.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 9.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 1.7 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 2.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 4.2 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 4.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 1.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 1.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.2 | 5.6 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.2 | 19.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 1.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 7.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.8 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.2 | 1.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 1.0 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.8 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.2 | 6.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 1.8 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 3.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 1.0 | GO:0010736 | serum response element binding(GO:0010736) |
0.2 | 4.2 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 1.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 40.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 1.7 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 3.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 2.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 0.5 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.2 | 5.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 2.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 4.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 4.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 1.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 21.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 1.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 8.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 3.3 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.2 | 1.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 1.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 1.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 1.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 6.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 2.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 1.4 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.6 | GO:0003917 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
0.2 | 1.2 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 3.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 11.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.7 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 3.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.4 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.1 | 4.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 7.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 2.4 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 5.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.1 | 1.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 3.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.9 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 2.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 1.6 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 7.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 2.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 2.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 11.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.5 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.1 | 0.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.9 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.6 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.1 | 18.1 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 3.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 22.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 3.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 3.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 4.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 2.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 3.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 3.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 8.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.1 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 1.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.8 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 1.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 3.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.8 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 1.0 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.1 | 1.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.1 | 3.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 4.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 4.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 1.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 1.9 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 1.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.5 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 1.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 23.2 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 0.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 1.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 1.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 2.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.5 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.4 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 0.1 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.1 | 7.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 1.4 | GO:0009931 | MAP kinase kinase activity(GO:0004708) calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.2 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
0.1 | 1.5 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.3 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.1 | 2.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 2.3 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.5 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 1.4 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.7 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 2.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 3.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 3.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 29.7 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 1.7 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.7 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 4.3 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 4.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 17.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 2.3 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 1.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 5.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 1.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 2.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 1.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 4.3 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 1.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.6 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 2.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 7.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 1.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.4 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 6.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 2.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 1.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.8 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
0.0 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 1.8 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 24.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 1.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 1.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 2.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 1.5 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 1.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 2.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 1.8 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 5.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 4.1 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 1.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 3.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.1 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.0 | 0.0 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.0 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.2 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.3 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.0 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
0.0 | 0.8 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 9.9 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.2 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.7 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 45.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.6 | 21.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 12.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 19.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 4.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 11.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 43.3 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 30.4 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.3 | 26.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 22.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 13.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 8.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 29.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 37.8 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 7.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 2.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 6.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 1.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 19.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 0.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 5.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 7.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 9.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 3.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 2.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 6.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 3.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 7.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 10.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 5.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 1.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 3.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 4.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 8.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 7.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 5.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 5.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 9.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 2.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 6.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 2.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 3.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 4.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 2.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 19.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 4.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 3.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 3.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.4 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 2.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 3.5 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 2.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 3.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 1.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 4.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 1.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 7.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 22.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 6.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.5 | 14.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 17.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.5 | 40.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 9.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 0.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.3 | 12.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 1.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 9.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 14.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 10.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 2.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 6.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 6.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 7.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 8.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 7.3 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.2 | 4.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 6.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 0.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 4.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 6.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 10.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 5.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 2.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 3.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 5.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 20.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 2.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 20.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 2.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 7.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 11.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 6.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 6.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 0.8 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.2 | 3.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 15.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 18.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 2.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 4.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 6.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 6.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 4.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 2.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 2.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 2.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 2.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 3.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 2.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 6.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 3.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 2.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 2.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 3.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 12.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 2.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 3.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 2.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 1.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 2.9 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 1.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 2.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 2.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 9.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 1.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.6 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 1.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 2.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.3 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 0.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 5.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 2.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 3.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.9 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 4.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 2.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 2.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 2.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 1.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 3.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 1.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 2.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 2.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.8 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 5.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 7.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 2.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 10.0 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 1.4 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |